Adherence to anti-osteoporotic therapy and five-year survival after fragility hip fracture: prognostic value of the MADiT stratification tool within a fracture liaison service
Key Points
Adherence to anti-osteoporotic therapy significantly influences five-year survival rates after fragility fractures, highlighting its importance.
Among the elderly, those following the MADiT stratification tool's recommendations had better survival outcomes than those who did not adhere.
The observational analysis utilized data from fracture liaison services, emphasizing the role of structured post-fracture care in patient management.
This finding supports the need for adherence promotion strategies, particularly in older populations recovering from hip fractures.
Like
Bookmark
Share
Like
Bookmark
Share
Adherence to anti-osteoporotic therapy and five-year survival after fragility hip fracture: prognostic value of the MADiT stratification tool within a fracture liaison service | Synapse